Loading this company
Loading this company
Priced above our range of A$5.59 to A$24.15.
A$39.70AUD unchanged A$0.00 (0.00%)
Quoted · Prices are delayed.
Showing the last price we hold for this listing, recorded 2026-10-19 15:55 UTC (9 hours ago).
Nothing we can cite explains today’s move for this company.
Our range from 4 models, on today’s numbers
A$5.59–A$24.15
What the price needs: revenue growth of more than 25%/yr for 5 years (our model assumes 8.9%), or investors accepting a ~5.0% discount rate, vs the 9.3% our model uses.
Led by discounted cash flow (DCF) · Steady cash-flow business
Price A$39.70Priced · Prices are delayed.
Our forward range over 12 months is part of Pro. See plans
Analysts’ mean target
A$37.37 across 8 analysts
The high and low of the analyst range is part of Pro. See plans
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. The company provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. It operates in the Medical Instruments & Supplies industry (Healthcare sector), headquartered in New Zealand. The company employs roughly 7,357 people.
Prices are delayed. The feed does not say when these figures were taken.
No filings or corporate activity on file in the recent window.
No recent headlines we can cite for this company.
No insider filings for this company in the recent window.
Not investment advice. TickerWorth Score is a model output.
The score, the fair value and the reverse DCF are free on every company. Pro lets you change growth, margin and the discount rate yourself, see every valuation lens and its working, and download the model. Start a 7-day free trial — a card is required and you can cancel any time before it ends. $99 a year, or $14.99 monthly.